Literature DB >> 17031746

HIDA scan ejection fraction does not predict sphincter of Oddi hypertension or clinical outcome in patients with suspected chronic acalculous cholecystitis.

S B Young1, M Arregui, K Singh.   

Abstract

BACKGROUND: Hepatobiliary iminodiacetic scan with ejection fraction (HIDA EF) is used to evaluate chronic acalculous cholecystitis (CAC). A presumed etiology of CAC is sphincter of Oddi hypertension (SOH). In this study, we evaluated the value of HIDA EF to predict patient response to laparoscopic cholecystectomy and to identify SOH.
METHODS: A prospective study of 93 patients with biliary pain but without gallstones (CAC) who underwent preoperative HIDA EF was conducted. At laparoscopic cholecystectomy, transcystic antegrade biliary manometry was performed to determine the SO pressure. Patients were evaluated postoperatively for response to cholecystectomy. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. The outcomes were compared with the clinical impression.
RESULTS: Of the 93 patients with both HIDA EF and SOP measurements, 50 had abnormal EF (< 35%); of these, 29 had SOH (SO pressure > or = 40 mmHg). Of the 43 patients with normal HIDA EF, 30 had SOH. The sensitivity was 49%, specificity 38%, PPV 58%, and NPV 30%. Eighty-six of the 93 patients returned for follow-up evaluation. Follow-up ranged from 0 to 99 months, with a mean of 26.4 months. Overall, 73 patients (85%) improved. Of the 46 with abnormal HIDA EF, 42 (91%) improved. Of the 40 patients with normal HIDA EF, 31 (77.5%) improved. The sensitivity was 57.7%, specificity 69.2%, PPV 91.3%, and NPV 22.5%.
CONCLUSION: Although the PPV of abnormal HIDA EF is high, it is not much better than the clinical impression. The sensitivity and specificity are marginal. The NPV is poor. Based on the review of these 93 patients, HIDA EF is not reliable for identifying CAC. We recommend that patients with normal HIDA EF have additional testing or consultation before ruling out CAC. HIDA EF does not predict SOH.

Entities:  

Mesh:

Year:  2006        PMID: 17031746     DOI: 10.1007/s00464-005-0245-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  43 in total

Review 1.  Does gallbladder ejection fraction predict outcome after cholecystectomy for suspected chronic acalculous gallbladder dysfunction? A systematic review.

Authors:  John K DiBaise; Dmitry Oleynikov
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

Review 2.  Functional disorders of the biliary tract and pancreas.

Authors:  E Corazziari; E A Shaffer; W J Hogan; S Sherman; J Toouli
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

3.  The clinical utility of quantitative cholescintigraphy: the significance of gallbladder dysfunction.

Authors:  P S Klieger; R E O'Mara
Journal:  Clin Nucl Med       Date:  1998-05       Impact factor: 7.794

4.  Effectiveness of cholecystokinin-stimulated cholescintigraphy in the diagnosis and treatment of acalculous gallbladder disease.

Authors:  M T Mishkind; R F Pruitt; D A Bambini; A M Hakenewerth; M H Thomason; J H Zuger; T Novick
Journal:  Am Surg       Date:  1997-09       Impact factor: 0.688

5.  Outcome after laparoscopic cholecystectomy for chronic acalculous cholecystitis.

Authors:  D B Adams; P R Tarnasky; R H Hawes; J T Cunningham; C Brooker; T E Brothers; P B Cotton
Journal:  Am Surg       Date:  1998-01       Impact factor: 0.688

6.  Cholecystokinin cholescintigraphy: detection of abnormal gallbladder motor function in patients with chronic acalculous gallbladder disease.

Authors:  D Fink-Bennett; P DeRidder; W Z Kolozsi; R Gordon; R Jaros
Journal:  J Nucl Med       Date:  1991-09       Impact factor: 10.057

7.  Gallbladder ejection fraction and symptom outcome in patients with acalculous biliary-like pain.

Authors:  Nuri Ozden; John K DiBaise
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

8.  Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy.

Authors:  L Yap; A G Wycherley; A D Morphett; J Toouli
Journal:  Gastroenterology       Date:  1991-09       Impact factor: 22.682

9.  Chronic acalculous cholecystitis: laparoscopic treatment.

Authors:  D B Jones; N J Soper; J D Brewer; M A Quasebarth; P E Swanson; S M Strasberg; L M Brunt
Journal:  Surg Laparosc Endosc       Date:  1996-04

10.  Cholecystokinin cholescintigraphy: methodology and normal values using a lactose-free fatty-meal food supplement.

Authors:  Harvey A Ziessman; Douglas A Jones; Larry R Muenz; Anup K Agarval
Journal:  J Nucl Med       Date:  2003-08       Impact factor: 10.057

View more
  5 in total

1.  Normokinetic biliary dyskinesia: a novel diagnosis.

Authors:  Christopher DuCoin; Robert Faber; Marlon Ilagan; William Ruderman; Daryl Wier
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

Review 2.  Cholecystectomy for biliary dyskinesia: how did we get there?

Authors:  Klaus Bielefeldt; Shreyas Saligram; Susan L Zickmund; Anwar Dudekula; Mojtaba Olyaee; Dhiraj Yadav
Journal:  Dig Dis Sci       Date:  2014-09-06       Impact factor: 3.199

3.  The cholecystokin provocation HIDA test: recreation of symptoms is superior to ejection fraction in predicting medium-term outcomes.

Authors:  Gareth Morris-Stiff; Gavin Falk; Laurel Kraynak; Steven Rosenblatt
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

4.  Evaluation of surgical outcomes and gallbladder characteristics in patients with biliary dyskinesia.

Authors:  M Shirin Sabbaghian; Barrie S Rich; Gary D Rothberger; Jonathan Cohen; Steven Batash; Elissa Kramer; H Leon Pachter; Stuart G Marcus; Peter Shamamian
Journal:  J Gastrointest Surg       Date:  2008-06-10       Impact factor: 3.452

5.  Diagnostic stringency and healthcare needs in patients with biliary dyskinesia.

Authors:  Nitin Aggarwal; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2013-08-11       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.